Alterity Therapeutics Ltd.ASX: ATH

Alterity to Present at the Craig-Hallum Biotech Conference

· Issued by Alterity Therapeutics Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Alterity Therapeutics announced its participation in a Fireside Chat at the Craig-Hallum Biotech Catalyst Conference, scheduled for a specific date and time. David Stamler, the Chief Executive Officer, will represent the company during this event. The company focuses on developing treatments for neurodegenerative diseases, particularly Parkinson’s disease and Multiple System Atrophy. This announcement was authorized by the CEO of Alterity Therapeutics.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/alterity-to-present-at-the-craig-hallum-biotech-conference

Release

Alterity Therapeutics to Participate in a Fireside Chat at the Craig-Hallum Biotech Catalyst Conference MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 19 October 2026: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...

Alterity Therapeutics Ltd. on 6ix

Story so far

Earlier from Alterity Therapeutics

Later from Alterity Therapeutics

All Alterity Therapeutics news releases